Correction to Lancet Gastroenterol Hepatol 2025; 10: 431-41 [0.03%]
肠道微生物组与异基因造血细胞移植后移植物抗宿主病复发和感染的关联：一项队列研究纠正原文献标题为《Correlation of gut microbiome with graft-versus-host disease relapse and infection after allogeneic haemopoietic cell transplantation: a cohort study》发表于《Lancet Gastroenterol Hepatol 2025; 10: 431-41》中的错误
The label of a diagnosis [0.03%]
诊断的标签
Cheryl Reeves
Cheryl Reeves
Clinical remission in ulcerative colitis: restoring precision in trial terminology [0.03%]
溃疡性结肠炎临床缓解：在试验术语中恢复精准性
Sailish Honap,Vipul Jairath,Fernando Magro et al.
Sailish Honap et al.
Efficacy differentiation of sterile faecal filtrates in Clostridioides difficile infection [0.03%]
用于难辨梭菌感染的灭活粪便滤过液的有效性差异分析
Stefan Schreiber,Philip Rosenstiel,Stephan J Ott et al.
Stefan Schreiber et al.
Efficacy differentiation of sterile faecal filtrates in Clostridioides difficile infection - Authors' reply [0.03%]
艰难梭菌感染无菌粪便滤液疗效差异——作者回信
Dina Kao,Huiping Xu,Thomas Louie
Dina Kao
The Lancet Gastroenterology Hepatology
The Lancet Gastroenterology Hepatology
Best buys for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a global Delphi study [0.03%]
代谢功能障碍相关脂肪肝病和代谢功能障碍相关肝炎的最佳购买全球德尔菲研究
Jeffrey V Lazarus,Leire Agirre-Garrido,Trenton M White et al.
Jeffrey V Lazarus et al.
Background: An estimated one in three adults is living with metabolic dysfunction-associated steatotic liver disease (MASLD) globally, among whom 20-25% progress to metabolic dysfunction-associated steatohepatitis (MASH)....
Dietary management of constipation: time for clinical guidelines to catch up with evidence [0.03%]
便秘的饮食管理：临床指南亟需跟上证据的步伐
Eirini Dimidi,Kevin Whelan
Eirini Dimidi
The Lancet Gastroenterology Hepatology
The Lancet Gastroenterology Hepatology